Biomarkers of inflammation and malnutrition associated with early death in healthy elderly people

Journal of the American Geriatrics Society

Volumn 56, Issue 5, 2008, Pages 840-846

  Carriere, Isabelle ^a,b,f   Dupuy, Anne Marie ^a,b,c   Lacroux, Annie ^d   Cristol, Jean Paul ^d   Delcourt, Cécile ^a,e  

^a INSERM   (France)

^b UNIV MONTPELLIER   (France)

^c LAPEYRONIE HOSPITAL   (France)

^d INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^e UNIVERSITÉ DE BORDEAUX   (France)

^f Montpellier 1 University   (France)

Author keywords

Frailty; Inflammation; Malnutrition; Mortality

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CHOLESTEROL; OROSOMUCOID; PREALBUMIN;

ADULT; AGED; AGING; ARTICLE; CANCER MORTALITY; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; DEATH; DISEASE ASSOCIATION; EARLY DEATH; FEMALE; FRANCE; GOOD GENERAL CONDITION; HAZARD RATIO; HIGH RISK POPULATION; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; POPULATION RESEARCH; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK ASSESSMENT; SEX DIFFERENCE;

EID: 43249127767     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2008.01677.x     Document Type: Article

References (36)

1. 1 Bortz W. A conceptual framework of frailty: A review. J Gerontol A Biol Sci Med Sci 2002 ; 57A: M283–M288.
2. 2 Walston J, Hadley EC, Ferrucci L et al. Research agenda for frailty in older adults: Toward a better understanding of physiology and etiology: Summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older Adults. J Am Geriatr Soc 2006 ; 54: 991–1001.
3. 3 Maggio M, Cappola AR, Ceda GP et al. The hormonal pathway to frailty in older men. J Endocrinol Invest 2005 ; 28: 15–19.
4. 4 Roubenoff R. Catabolism of aging: Is it an inflammatory process? Curr Opin Clin Nutr Metab Care 2003 ; 6: 295–299.
5. 5 Leng SX, Xue QL, Tian J et al. Inflammation and frailty in older women. J Am Geriatr Soc 2007 ; 55: 864–871.
6. 6 Walston J, McBurnie MA, Newman A et al. Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: Results from the Cardiovascular Health Study. Arch Intern Med 2002 ; 162: 2333–2341.
7. 7 Ferrucci L, Guralnik JM. Inflammation, hormones, and body composition at a crossroad. Am J Med 2003 ; 115: 501–502.
8. 8 Fried L, Tangen C, Walston J et al. Frailty in older adults: Evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001 ; 56A: M146–M156.
9. 9 Morley JE. Anorexia, sarcopenia, and aging. Nutrition 2001 ; 17: 660–663.
10. 10 Studenski S, Hayes R, Leibowitz R et al. Clinical global impression of change in physical frailty: Development of a measure based on clinical judgment. J Am Geriatr Soc 2004 ; 52: 1560–1566.
11. 11 Chin A Paw M, Dekker J, Feskens E et al. How to select a frail elderly population? A comparison of three working definitions. J Clin Epidemiol 1999 ; 52: 1015–1021.
12. 12 Ferrucci L, Guralnik J, Studenski S et al. Designing randomized, controlled trials aimed at preventing or delaying functional decline and disability in frail, older persons: A consensus report. J Am Geriatr Soc 2004 ; 52: 625–634.
13. 13 Carriere I, Colvez A, Favier F et al. Hierarchical components of physical frailty predict incidence of dependency in a cohort of elderly women. J Clin Epidemiol 2005 ; 58: 1172–1179.
14. 14 Fried L, Ferrucci L, Darer J et al. Untangling the concepts of disability, frailty, and comorbidity: Implications for improved targeting and care. J Gerontol A Biol Sci Med Sci 2004 ; 59A: 255–263.
15. 15 Hu P, Reuben DB, Crimmins EM et al. The effects of serum beta‐carotene concentration and burden of inflammation on all‐cause mortality risk in high‐functioning older persons: MacArthur Studies of Successful Aging. J Gerontol A Biol Sci Med Sci 2004 ; 59A: 849–854.
16. 16 Jenny NS, Yanez ND, Psaty BM et al. Inflammation biomarkers and near‐term death in older men. Am J Epidemiol 2007 ; 165: 684–695.
17. 17 Gill TM, Allore H, Holford TR et al. The development of insidious disability in activities of daily living among community‐living older persons. Am J Med 2004 ; 117: 484–491.
18. 18 Delcourt C, Diaz JL, Ponton‐Sanchez A et al. Smoking and age‐related macular degeneration. The POLA Study. Pathologies Oculaires Liées a l'Age. Arch Ophthalmol 1998 ; 116: 1031–1035.
19. 19 Ingenbleek Y, Carpentier YA. A prognostic inflammatory and nutritional index scoring critically ill patients. Int J Vitam Nutr Res 1985 ; 55: 91–101.
20. 20 Commenges D, Letenneur L, Joly P et al. Modelling age‐specific risk: Application to dementia. Stat Med 1998 ; 17: 1973–1988.
21. 21 Okamura T, Kadowaki T, Hayakawa T et al. What cause of mortality can we predict by cholesterol screening in the Japanese general population? J Intern Med 2003 ; 253: 169–180.
22. 22 Raynaud‐Simon A, Lafont S, Berr C et al. Orosomucoid: A mortality risk factor in elderly people living in the community? Clin Nutr 2002 ; 21: 45–50.
23. 23 Kistorp C, Raymond I, Pedersen F et al. N‐terminal pro‐brain natriuretic peptide, C‐reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults. JAMA 2005 ; 293: 1609–1616.
24. 24 Reuben DB, Cheh AI, Harris TB et al. Peripheral blood markers of inflammation predict mortality and functional decline in high‐functioning community‐dwelling older persons. J Am Geriatr Soc 2002 ; 50: 638–644.
25. 25 Hu P, Seeman TE, Harris TB et al. Does inflammation or undernutrition explain the low cholesterol‐mortality association in high‐functioning older persons? MacArthur Studies of Successful Aging. J Am Geriatr Soc 2003 ; 51: 80–84.
26. 26 Reuben DB, Ferrucci L, Wallace R et al. The prognostic value of serum albumin in healthy older persons with low and high serum interleukin‐6 (IL‐6) levels. J Am Geriatr Soc 2000 ; 48: 1404–1407.
27. 27 Gabay C, Kushner I. Acute‐phase proteins and other systemic responses to inflammation. N Engl J Med 1999 ; 340: 448–454.
28. 28 Stenvinkel P, Heimburger O, Lindholm B et al. Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol Dial Transplant 2000 ; 15: 953–960.
29. 29 Vanitallie TB. Frailty in the elderly: Contributions of sarcopenia and visceral protein depletion. Metabolism 2003 ; 52: 22–26.
30. 30 Devoto G, Gallo F, Marchello C et al. Prealbumin serum concentrations as a useful tool in the assessment of malnutrition in hospitalized patients. Clin Chem 2006 ; 52: 2281–2285.
31. 31 Cano NJ. Metabolism and clinical interest of serum transthyretin (prealbumin) in dialysis patients. Clin Chem Lab Med 2002 ; 40: 1313–1319.
32. 32 Sergi G, Coin A, Enzi G et al. Role of visceral proteins in detecting malnutrition in the elderly. Eur J Clin Nutr 2006 ; 60: 203–209.
33. 33 Blake GJ, Ridker PM. Inflammatory bio‐markers and cardiovascular risk prediction. J Intern Med 2002 ; 252: 283–294.
34. 34 Danesh J, Wheeler JG, Hirschfield GM et al. C‐reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004 ; 350: 1387–1397.
35. 35 Fruchart JC, Nierman MC, Stroes ES et al. New risk factors for atherosclerosis and patient risk assessment. Circulation 2004 ; 109: III15–III19.
36. 36 Caruso C, Lio D, Cavallone L et al. Aging, longevity, inflammation, and cancer. Ann NY Acad Sci 2004 ; 1028: 1–13.